
|Articles|September 13, 2017
Should the Availability of High-Dose Opioids Be Reduced?
In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses whether the FDA should reduce the availability of high-dose opioids in response to the growing opioid abuse epidemic.
Advertisement
In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses whether the FDA should reduce the availability of high-dose opioids in response to the growing opioid abuse epidemic.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
World Lung Cancer Day: Pharmacists Are Essential Across Prevention, Screening, and Treatment
2
A Pharmacist's Guide to Probiotics for Preventing Traveler’s Diarrhea
3
July 2026 in Pain Management: 10 Developments That Advanced and Challenged Patient Care
4
Five Solid Tumor Advances That Defined July 2026
5





































































































